The effect of lifestyle modification on depression among myocardial infarction patients after revascularisation

Aminu Arzet1, Wilbert Sibanda2, D P Naidoo3

  • 1Department of Medicine, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Insights

Lifestyle modification (LSM) effectively reduces depression in patients with coronary artery disease (CAD) after revascularization. Adherence to LSM is key, regardless of whether patients undergo coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Patients with coronary artery disease (CAD) exhibit a high prevalence of depression, which is linked to adverse cardiac outcomes.
  • Lifestyle modification (LSM) is recognized for its benefits in managing depression among CAD patients.
  • The impact of cardiac intervention type (coronary artery bypass graft surgery [CABG] vs. percutaneous coronary intervention [PCI]) on depression outcomes remains unclear.

Purpose of the Study:

  • To investigate the prevalence of depression in myocardial infarction (MI) patients post-revascularization.
  • To compare the effectiveness of LSM in reducing depression incidence between CABG and PCI patient groups.

Main Methods:

  • Evaluated risk factors, depression characteristics, and lifestyle changes in 100 consecutive coronary revascularization patients.
  • Utilized the Beck Depression Inventory II (BDI-II) for depression assessment and the Goldin leisure-time exercise (GLTE) questionnaire for physical activity (PA) evaluation.

Main Results:

  • Pre-LSM, 51% of patients had depression; post-LSM, this decreased to 34.7%.
  • Depression prevalence was higher in CABG patients (66.7%) pre-LSM and post-LSM (72.0%) compared to PCI patients (33.3% and 23.0%, respectively).
  • Fully compliant patients showed similar LSM benefits regardless of intervention type (CABG vs. PCI).
  • Key predictors of depression included female gender, CABG, heart failure, kidney failure, atrial fibrillation, low physical activity, prior depression history, and low income.

Conclusions:

  • Depression is common after coronary revascularization, particularly in CABG patients.
  • LSM significantly reduces depression prevalence, with comparable benefits for fully compliant CABG and PCI patients.
  • Lack of lifestyle modification and physical activity engagement are significant barriers to managing depression post-revascularization.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
102
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
86
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
111
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
112
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
59
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
110